Natalia T Freund

Thrilled to share that our @freund_lab work on the antibody response against #MPXV A28 protein is now on @NatureComms ! Huge thanks to @Guardado_Calvo, @Virus_Immunity, @OrenKobiler, @LabAdler, @Fishelsonlab, @SouraskyMedCtr and @TAUMedFaculty. More in🧵 nature.com/articles/s4146…

For the first time in history, researchers led by Prof. Tal Dvir are preparing to implant an engineered human spinal cord into paralyzed patients. After animal trials showed that 80% regained full walking ability, the world’s first human trial is about to begin — right here in Israel. A medical revolution is on the horizon, born at TAU. More: english.tau.ac.il/research/engin… Developed at the Sagol Center for Regenerative Biotechnology, Tel Aviv University, in partnership with Matricelf.

At the same time across the globe… my once-tiny baby reunites with my incredible friend- who somehow became *his* PI 🤯🧪 From diapers to data at @freund_lab @TelAvivUni!

1/11 New preprint alert! Our latest @freund_lab study in which we dissect how the immune system fights #Mpox and identify potent human neutralizing monoclonal antibodies (#mAbs) that target a novel key viral protein, #MpoxA28. Now on biorxiv: biorxiv.org/content/10.110…🧵

Exclusive: These universities have the most retracted scientific articles A first-of-its-kind analysis reveals which institutions are retraction hotspots Read the full story here: go.nature.com/4gMhkmG